Related Experiment Video
Updated: Feb 3, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Anticoagulant Therapy in Elderly Patients With Atrial Fibrillation]
Y N Belenkov1, G A SHakaryants1, N V Khabarova1
1I.M. Sechenov First Moscow State Medical University (Sechenov University).
Insights
This paper examines anticoagulant therapy challenges in elderly atrial fibrillation patients, focusing on low-dose risks and adherence issues to improve treatment outcomes.
Area of Science:
- Geriatric Medicine
- Cardiology
- Pharmacology
Background:
- Atrial fibrillation necessitates anticoagulant therapy for stroke prevention.
- Elderly patients present unique challenges in managing anticoagulation.
- Suboptimal dosing and poor adherence are significant clinical concerns.
Purpose of the Study:
- To review the complexities of selecting anticoagulant therapy for elderly patients with atrial fibrillation.
- To analyze the risks associated with using low-dose anticoagulants in this population.
- To explore factors influencing adherence to anticoagulant therapy.
Main Methods:
- Literature review of studies on anticoagulant use in elderly atrial fibrillation patients.
- Analysis of data regarding dosing strategies, adverse events, and patient adherence.
- Discussion of clinical guidelines and best practices.
Main Results:
- Elderly patients often receive inappropriately low doses of anticoagulants.
- Low-dose anticoagulation increases the risk of thromboembolic events.
- Adherence to anticoagulant therapy is frequently suboptimal in this demographic.
Conclusions:
- Optimizing anticoagulant selection and dosing is crucial for elderly atrial fibrillation patients.
- Addressing adherence barriers is essential for effective stroke prevention.
- Further research is needed to refine anticoagulant management strategies for geriatric populations.
Abstract:
Is this paper discuss problems of selection of anticoagulant therapy in elderly patients with atrial fibrillation, use of unreasonably low doses of anticoagulants, their risks and adherence to therapy is discussed in the paper.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Gene Therapy

